MGNX Receives $24.5M Milestone
MacroGenics to receive $24.5M milestone from Sanofi following FDA approval of TZIELD expansion in type 1 diabetes
MacroGenics To Receive $24.5M Milestone From Sanofi Following FDA Approval Of TZIELD Expansion In Type 1 Diabetes